Background: Xpert MTB-Host Response (MTB-HR) has reached WHO test targets for pulmonary tuberculosis (PTB) with high bacillary loads. Our aim was to investigate the contribution of MTB-HR as a non-sputum, near point-of-care (POC) method for diagnosis of other prioritized groups, where MTB detection is more complicated, such as extrapulmonary tuberculosis (EPTB) and paucibacillary PTB.
Methods: Individuals with presumed TB disease were prospectively included in Stockholm, Sweden (n=307) and underwent MTB-HR venous and capillary testing in parallel.
Introduction: Malaria remains a significant burden, and a fully protective vaccine against is critical for reducing morbidity and mortality. Antibody responses against the blood-stage antigen Merozoite Surface Protein 2 (MSP2) are associated with protection from malaria, but its extensive polymorphism is a barrier to its development as a vaccine candidate. New tools, such as long-read sequencing and accurate protein structure modelling allow us to study the genetic diversity and immune responses towards antigens from clinical isolates with unprecedented detail.
View Article and Find Full Text PDFFront Endocrinol (Lausanne)
October 2024
the causative agent of tuberculosis (TB), is a leading cause of death by an infectious disease globally, with no efficacious vaccine. Antibodies are implicated in control, but the mechanisms of antibody action remain poorly understood. We assembled a library of TB monoclonal antibodies (mAb) and screened for the ability to restrict in mice, identifying protective antibodies targeting known and novel antigens.
View Article and Find Full Text PDFCD11c, FcRL5, or T-bet are commonly expressed by B cells expanding during inflammation, where they can make up >30% of mature B cells. However, the association between the proteins and differentiation and function in the host response remains largely unclear. We have assessed the co-expression of CD11c, T-bet, and FcRL5 in an in vitro B-cell culture system to determine how stimulation via the BCR, toll-like receptor 9 (TLR9), and different cytokines influence CD11c, T-bet, and FcRL5 expression.
View Article and Find Full Text PDF